Also, GM-CSF, an immune modulatory cytokine that has the ability to induce proliferation of granulocyte and macrophage populations from precursor cells and to activate T-cell immune response, was significantly higher in HFRS patients in comparison to the control group (Figure 1). This evidence concerns the gene CSF2 and hemorrhagic fever with renal syndrome.